|
|
Lambda Therapeutic Research - Poland:
 |
Capabilities:
 |
43 beds in clinical unit for Phase I and BE studies |
 |
Proof of Concept Pharmacokinetic studies |
 |
Phase II-IV clinical trials in Poland and CEE region
|
|
 |
Experience:
| Study phase |
Number of
studies |
Number of patients |
Therapeutic
area/substance |
| I |
2 completed
1 ongoing |
40 |
PK study, cystine, urology |
| II |
5 completed |
140 |
R.A., Irritable Bowl
Syndrome, Assisted Reproductive Technologies -
hyperstimulation |
| III |
3 completed
3 ongoing |
410 |
COPD, Hip
osteoarthrthritis, Arterial Hypertension |
|
BE Studies |
27 completed
6 ongoing |
1185 |
Bromocriptine, Clopidogrel, Digoxin, Diltiazem, Itraconazole, Olanzepine, Ibuprofen, Risedronate, Topiramate, Tamsulosine, Ropinirole, Nicergoline, Pravastatine, Montelukast |

|
|
|